| 21-May-13 01:29PM | Array BioPharma's CEO Presents at 2013 UBS Global Life Sciences Conference (Transcript) at Seeking Alpha |
| 16-May-13 04:34PM | Array BioPharma's CEO Presents at Bank of America Merrill Lynch Healthcare Conference (Transcript) at Seeking Alpha |
| 02:00AM | AstraZeneca Advances Three Cancer Drugs Into Late-Stage Trials at Bloomberg |
| 01:00AM | Part 3: Will Array BioPharma Become A Late Stage Biopharmaceutical Company? at Seeking Alpha |
| 15-May-13 08:00AM | Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting PR Newswire |
| 05:45AM | Array Biopharma: Measuring The Strength Of This Small-Cap Pharma Stock at Seeking Alpha |
| 14-May-13 01:04PM | ARRAY BIOPHARMA INC Financials EDGAR Online Financials |
| 12-May-13 06:21PM | Part 2: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company? at Seeking Alpha |
| 06:06PM | Part 1: Will Array BioPharma Become A Late-Stage Biopharmaceutical Company? at Seeking Alpha |
| 08-May-13 08:00AM | Array BioPharma to Present at the Bank of America Merrill Lynch Healthcare Conference and the UBS Global Healthcare Conference PR Newswire |
| 07-May-13 03:32PM | Array BioPharma's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha -9.66% |
| 10:16AM | ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 09:01AM | Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy at Seeking Alpha |
| 09:00AM | Array BioPharma Inc. Earnings Call scheduled for 9:00 am ET today CCBN |
| 06-May-13 06:01PM | Array BioPharma Earnings: Heres Why Shares are Up Now at Wall St. Cheat Sheet |
| 04:05PM | Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013 PR Newswire |
| 04:04PM | Array BioPharma to initiate Phase 3 trial evaluating MEK162 theflyonthewall.com |
| 04:01PM | InPlay: Array Biopharma announces global phase 3 trial evaluating MEK162 in patients with low-grade serous ovarian cancer Briefing.com |
| 04:00PM | Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer PR Newswire |
| 09:08AM | ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online |
| 09:03AM | ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 07:07AM | Q3 2013 Array BioPharma Inc. Earnings Release - After Market Close CCBN |
| 30-Apr-13 11:42AM | These 3 Biotech Stocks Look Interesting at Motley Fool |
| 29-Apr-13 01:28PM | Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2013 On May 6, 2013 PR Newswire |
| 11:02AM | Brian Skorney, Senior Analyst at Robert W. Baird & Co., Interviews with The Wall Street Transcript: FDA Approvals Accelerate and Opportunities Arise in Hepatitis C Market Wall Street Transcript |
| 17-Apr-13 05:00AM | Array's Up-Coming Value Enhancing Catalysts at Seeking Alpha |
| 10-Apr-13 05:50PM | Array Presents ARRY-520 Data Zacks |
| 09-Apr-13 04:00PM | Gilead Seeks FDA Approval Zacks |
| 08-Apr-13 05:45PM | Regeneron Aims HQ Expansion Zacks |
| 05:10PM | BMY Announces Management Changes Zacks |
| 05-Apr-13 05:18PM | R&D and Iclusig Update from Ariad Zacks |
| 04-Apr-13 04:48PM | 4 Healthcare Stock Stories for Thursday Investment Wellness at Wall St. Cheat Sheet |
| 03:43PM | Orphan Status for Insmed's Arikace Zacks |
| 08:33AM | InPlay: Array Biopharma provides updates on ARRY-520 clinical data; ARRY-520 demonstrated single agent activity in heavily pretreated patients Briefing.com |
| 08:30AM | Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop PR Newswire |
| 01:31AM | ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 03-Apr-13 09:18AM | BioMarin Files CTA for BMN-190 Zacks |
| 02-Apr-13 03:43PM | BMRN Seeks US Approval of Vimizim Zacks |
| 02:36PM | 4 Health Care Stocks Under $10 to Watch at TheStreet |
| 01-Apr-13 06:03PM | ANTH's Blisibimod Enters Phase III Zacks |
| 06:48AM | The Morning Ledger: Spending Cuts May Not Hamper Job Growth at The Wall Street Journal |
| 29-Mar-13 01:57PM | At-The-Market Offerings Bring Cost Savings: Array CFO at The Wall Street Journal |
| 28-Mar-13 04:14PM | Array BioPharma: An Exciting Year Ahead at Seeking Alpha |
| 27-Mar-13 09:33AM | ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online |
| 26-Mar-13 01:22PM | Is Merck's Type 2 Diabetes Blockbuster in Trouble? at Motley Fool +6.25% |
| 12:31PM | On The Fly: Midday Wrap theflyonthewall.com |
| 10:04AM | On The Fly: Analyst Upgrade Summary theflyonthewall.com |
| 25-Mar-13 04:40PM | Piper Jaffray Likes Array, Should You? at Seeking Alpha +8.16% |
| 03:33PM | Pipeline Setback at BioLineRx Zacks |
| 12:29PM | On The Fly: Midday Wrap theflyonthewall.com |
| 12:05PM | Why Array Biopharma Shares Popped at Motley Fool |
| 10:02AM | On The Fly: Analyst Upgrade Summary theflyonthewall.com |
| 24-Mar-13 11:02PM | ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits EDGAR Online |
| 21-Mar-13 05:18PM | Data on BioMarin's BMN-701 Zacks |
| 04:00PM | InPlay: Array Biopharma names Michael Needle as Chief Medical Officer Briefing.com |
| 04:00PM | Array BioPharma Names Michael N. Needle, M.D. As Chief Medical Officer PR Newswire |
| 20-Mar-13 04:18PM | Santarus' Uceris Data Published Zacks |
| 08:28AM | Synergy Posts Wider Loss Zacks |
| 19-Mar-13 05:20PM | Alnylam Initiates ALN-TTRsc Study Zacks |
| 18-Mar-13 04:08PM | Theravance Inks Deal for Vibativ Zacks |
| 15-Mar-13 03:43PM | BioLineRx to Initiate HCV Study Zacks |
| 03:42PM | 4Q Loss Narrows at Xenoport Zacks |
| 14-Mar-13 08:20AM | Programs by the FDA Designed to Speed Up Approval Process for Critical Drugs a Key Factor in Biotech's Industry Success Marketwire |
| 13-Mar-13 04:48PM | Peregrine Reports Narrower Loss Zacks |
| 09:18AM | Gilead Hits 52-Week High Zacks |
| 12-Mar-13 05:21PM | CBST Gets Global Rights to Antibiotic Candidate Zacks |
| 01:18PM | Encouraging Data Presented by Gilead Zacks |
| 11-Mar-13 03:28PM | Pharmacyclics to Sell Shares Zacks |
| 01:33PM | Santarus Tops, Focus on Zegerid Zacks |
| 07-Mar-13 01:08PM | Good News for Gilead's HIV Pipeline Zacks |
| 12:10PM | Nektar Loss Widens, Gives Guidance Zacks |
| 06-Mar-13 05:08PM | Bayer, Children's Hospital Oakland target sickle cell, other blood diseases in research pact at bizjournals.com |
| 11:48AM | Vertex Flu Drug Shows Promise Zacks |
| 05-Mar-13 04:00PM | InPlay: Array Biopharma and Global Blood Therapeutics announce drug discovery collaboration focused on hematology Briefing.com |
| 04:00PM | Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology PR Newswire |
| 01:08PM | Regeneron to Earn More Royalty Zacks |
| 12:48PM | JAZZ Beats EPS, Misses Sales Zacks |
| 12:46PM | Loss at Dynavax Wider than Expected Zacks |
| 04-Mar-13 12:58PM | Celgene's Apremilast Encourages Zacks |
| 08:20AM | Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire |
| 01-Mar-13 04:28PM | Encouraging News for Cubist Pharma Zacks +9.77% |
| 09:37AM | Idenix Reports In-Line 4Q Loss Zacks |
| 08:28AM | Medivation Beats 4Q Expectations Zacks |
| 08:20AM | Biotech Industry Soars in 2012 as FDA Drug Approvals Reach a 15-Year High Marketwire |
| 26-Feb-13 04:53PM | Cubist Pharma Inks Deal Zacks |
| 09:00AM | Array BioPharma To Present At The Cowen Annual Health Care Conference PR Newswire |
| 25-Feb-13 07:52AM | Hunt for Black Swans May Just Be Getting Started at CNBC -7.13% |
| 21-Feb-13 04:18PM | Celgene Plans $600M Share Buyback Zacks |
| 12:58PM | Gilead and Teva Bury the Hatchet Zacks |
| 20-Feb-13 12:58PM | Gilead Presents Positive HCV Data Zacks |
| 07:28AM | Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma Zacks |
| 19-Feb-13 04:43PM | Pipeline Progress at Bayer/Regeneron Zacks |
| 15-Feb-13 02:01PM | Eylea Drives Regeneron Zacks |
| 14-Feb-13 02:37PM | Alexion 4Q Tops on Both Lines Zacks |
| 12-Feb-13 01:04PM | ARRAY BIOPHARMA INC Financials EDGAR Online Financials |
| 08:38AM | Zacks Rank #1 Addition for Tuesday Zacks |
| 11-Feb-13 04:58PM | Colorado stocks: Starz up 7% on news of Sony deal at bizjournals.com |
| 08:05AM | Celgene Gets OK to Sell Blood Cancer Drug at Minyanville |
| 09-Feb-13 02:51PM | Array expects to make progress on generating data on hematology programs theflyonthewall.com |
| 08-Feb-13 06:45PM | Array BioPharma To Present At The Leerink Swann Global Healthcare Conference PR Newswire |
